Conventional Synthetic Disease-modifying Drugs Remain the Mainstay of Therapy for Rheumatoid Arthritis in India.
Dhir V, Chiu SM, Gupta R, Phillip SS, Shenoy P, Taksande B, Rawal D, Kumar K, Singh G, Kumar S, Dhuria S, Manovihar A, Bhagat A, Soni C, Jain S, Shobha V.
Dhir V, et al. Among authors: gupta r.
J Assoc Physicians India. 2024 Dec;72(12):30-33. doi: 10.59556/japi.72.0756.
J Assoc Physicians India. 2024.
PMID: 39676184